Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Triple Negative Breast Neoplasms
×
capivasertib
×
Clear all
Filters
3
NCT03742102
2026-02-02
BEGONIA
AstraZeneca
Phase 1/2
Active not recruiting
243 enrolled
13 charts